ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 229 filers reported holding ARENA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 2.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $418,000 | +56.0% | 4,500 | 0.0% | 0.01% | +50.0% |
Q3 2021 | $268,000 | -12.7% | 4,500 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $307,000 | -1.6% | 4,500 | 0.0% | 0.01% | -14.3% |
Q1 2021 | $312,000 | -9.8% | 4,500 | 0.0% | 0.01% | -41.7% |
Q4 2020 | $346,000 | +2.7% | 4,500 | 0.0% | 0.01% | -14.3% |
Q3 2020 | $337,000 | +19.1% | 4,500 | 0.0% | 0.01% | +40.0% |
Q2 2020 | $283,000 | +38.7% | 4,500 | 0.0% | 0.01% | +66.7% |
Q4 2019 | $204,000 | -1.0% | 4,500 | 0.0% | 0.01% | 0.0% |
Q3 2019 | $206,000 | -22.0% | 4,500 | 0.0% | 0.01% | -14.3% |
Q2 2019 | $264,000 | +30.7% | 4,500 | 0.0% | 0.01% | +16.7% |
Q1 2019 | $202,000 | – | 4,500 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 163,133 | $7,467,000 | 4.14% |
PFM Health Sciences, LP | 2,271,536 | $103,968,000 | 3.07% |
Partner Investment Management, L.P. | 28,877 | $1,322,000 | 2.26% |
Atika Capital Management LLC | 181,000 | $8,284,000 | 1.74% |
DAFNA Capital Management LLC | 93,942 | $4,300,000 | 1.62% |
Asymmetry Capital Management, L.P. | 16,272 | $745,000 | 1.60% |
First Light Asset Management, LLC | 190,838 | $8,735,000 | 1.32% |
Perceptive Advisors | 953,129 | $43,624,000 | 1.18% |
Rhenman & Partners Asset Management AB | 155,000 | $7,094,000 | 0.89% |
Opus Point Partners Management, LLC | 9,770 | $447,000 | 0.81% |